勃林格殷格翰与英国生物科技公司达成5亿美元协议,开发口服自身免疫疾病疗法。
Boehringer pens $500M pact with British biotech for oral approach to autoimmune diseases
生物技术与制药领域的最新动态
Boehringer pens $500M pact with British biotech for oral approach to autoimmune diseases
Bristol Myers' $800M ADC hits primary survival endpoints in phase 3 breast cancer trial
Quantum Surgical snaps up J&J's NeuWave Medical for its microwave ablation technology
Protagonist plans to pocket $400M from Takeda rather than split US rusfertide profits
SPT Labtech to collaborate with Illumina to develop automated platform supporting genomics in decentralized healthcare settings - the-scientist.com
AI Drug Discovery: How Roche Accelerates Health Innovation - AI Magazine
Barclays Has Lowered Expectations for Agilent Technologies (NYSE:A) Stock Price - MarketBeat
Protagonist to opt out of Takeda profit-sharing deal, will receive $400M in cash
Novartis to build another radioligand factory; Germany steps up probe into Gerresheimer
Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026 - BioSpace
Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner - BioSpace
Westpac Banking Corp Increases Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Salma Health raises $80M for its clinics to treat brain health
A Live-Cell NanoBRET Assay Shines Light on Toxic RNA–Protein Interactions in Myotonic Dystrophy
Gan & Lee Pharmaceuticals patents SMARCA2/4-degrading PROTACs
Cathepsin L inhibitors disclosed in Biofront Therapeutics patent
MSD patent details new WRN inhibitors for cancer
Retex Pharmaceuticals divulges vasopressin V2 receptor antagonists
Sarepta CEO Doug Ingram to retire, with company at a crossroads
Biohaven says FDA roadblocks leave rare disease patients in limbo